Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics, Inc. - Common Stock
(NQ:
SRPT
)
15.00
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sarepta Therapeutics, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
35
36
Next >
Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
July 25, 2025
Via
Benzinga
Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union
July 25, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Friday's pre-market session: top gainers and losers
↗
July 25, 2025
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
Arrowhead Pharma Expects Sarepta Therapeutics To Continue Meeting Financial Obligations: Retail Cheers The Announcement
↗
July 23, 2025
Via
Stocktwits
Sarepta Pauses Shipments Of DMD Drug Elevidys Amid FDA Label Review, Stock Tumbles After-Hours
↗
July 21, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 25, 2025
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm
July 24, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
The Hits Keep Coming For Sarepta. Why Its Latest Setback Creates A 'Dangerous Precedent' For Gene Therapies.
↗
July 24, 2025
Sarepta stock is now trading at a nine-year low as the debacle with its gene therapy, Elevidys, continues.
Via
Investor's Business Daily
Topics
Death
Workforce
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 24, 2025
Via
Benzinga
Sarepta Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Sarepta Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - SRPT
July 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Sarepta Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Sarepta Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - SRPT
July 24, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
↗
July 24, 2025
Via
Benzinga
Is This Stock a Buy After Soaring by 20% in 1 Day?
↗
July 24, 2025
Via
The Motley Fool
Topics
Death
Elevidys Halt Sparks Analyst Downgrades—Sarepta Races To Revise Label
↗
July 23, 2025
Analysts downgraded Sarepta as FDA pause on Elevidys raises regulatory uncertainty, leading to significant stock pressure and valuation cuts.
Via
Benzinga
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT
July 23, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc. (SRPT) Shareholders
July 23, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc. (SRPT) Shareholders
July 23, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
↗
July 22, 2025
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and drug advertising rules.
Via
Benzinga
Sarepta Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT
July 22, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Sarepta Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT
July 22, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Sarepta Tumbles On The 'Painful' Decision To Stop Selling Elevidys
↗
July 22, 2025
Sarepta stock toppled Tuesday after the company said it would voluntarily stop all shipments of Elevidys.
Via
Investor's Business Daily
Topics
Death
ETFs
Sarepta Reverses Course, Pauses Elevidys Shipments Amid FDA Safety Review
↗
July 22, 2025
Sarepta pauses U.S. Elevidys shipments to complete FDA-requested safety label updates, aiming to resume distribution in the fourth quarter.
Via
Benzinga
Agilysys Posts Downbeat Earnings, Joins NXP Semiconductors And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
July 22, 2025
Via
Benzinga
This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
↗
July 22, 2025
Via
Benzinga
Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S.
July 21, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Faces Regulatory Showdown As Analysts Cut Price Targets
↗
July 21, 2025
Sarepta faces FDA scrutiny over Elevidys as analysts downgrade stock and warn of long-term debt risks amid market uncertainty.
Via
Benzinga
Sarepta Topples, Again, After Refusing The FDA's Request To Pull Elevidys
↗
July 21, 2025
The company is setting up for a showdown with the FDA over its approved gene therapy, Elevidys.
Via
Investor's Business Daily
Topics
Death
Government
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Sarepta Therapeutics, Inc. (SRPT)
July 21, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Sarepta Therapeutics, Inc. (SRPT)
July 21, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 21, 2025
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
